This peptide is primarily used in neuroscience research to study synaptic plasticity and memory formation. It is designed to interfere with the internalization of AMPA receptors, specifically the GluA2 subunit, which plays a critical role in long-term depression (LTD) in the brain. By blocking this process, it helps researchers understand the mechanisms underlying learning and memory. Additionally, it is utilized in studies focused on neurological disorders such as Alzheimer's disease, where synaptic dysfunction is a key feature. Its application provides insights into potential therapeutic targets for cognitive impairments.